Eastman Chemical (EMN) Liabilities and Shareholders Equity (2009 - 2026)

Eastman Chemical's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $15.2 billion for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 1.68% year-over-year to $15.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.3 billion (changed 0.15% YoY) and the FY2025 annual result came in at $14.9 billion, down 2.33% from the prior year.
• Liabilities and Shareholders Equity was $15.2 billion for Q1 2026 at Eastman Chemical, up from $14.9 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $15.8 billion in Q1 2022 and bottomed at $14.6 billion in Q3 2023.
• A 5-year average of $15.0 billion and a median of $15.0 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 7.84% — and 2024, when it climbed 3.96%.
• Eastman Chemical's Liabilities and Shareholders Equity stood at $14.7 billion in 2022, then slipped by 0.23% to $14.6 billion in 2023, then climbed by 3.96% to $15.2 billion in 2024, then decreased by 2.33% to $14.9 billion in 2025, then rose by 2.44% to $15.2 billion in 2026.
• Business Quant data shows EMN's Liabilities and Shareholders Equity at $15.2 billion in Q1 2026, $14.9 billion in Q4 2025, and $15.0 billion in Q3 2025.